Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163893 | SCV000214484 | likely benign | Hereditary cancer-predisposing syndrome | 2017-05-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000229260 | SCV000285231 | benign | Tuberous sclerosis 2 | 2024-11-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000616256 | SCV000727595 | likely benign | not specified | 2018-02-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV000229260 | SCV002041311 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002505202 | SCV002797909 | likely benign | Lymphangiomyomatosis; Isolated focal cortical dysplasia type II; Tuberous sclerosis 2 | 2021-08-27 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003995294 | SCV004819243 | likely benign | Tuberous sclerosis syndrome | 2023-12-13 | criteria provided, single submitter | clinical testing |